| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |